Carmat Company Description

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally.

Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure.

The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

Carmat SA

Country	France
Founded	2008
Industry	Medical Devices
Sector	Healthcare
Employees	182
CEO	Stephane Piat

Contact Details

Address: 36, avenue de l'Europe Vélizy-Villacoublay, 78140 France
Phone	33 1 39 45 64 50
Website	carmatsa.com

Stock Details

Ticker Symbol	ALCAR
Exchange	Euronext Paris
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	FR0010907956
SIC Code	3845

Key Executives

Name	Position
Stephane Piat	Chief Executive Officer and Director
Pascale d'Arbonneau	Chief Financial Officer and Head of investor relations
Raouia Bouyanzer	Human Resources Director
Dr. Petrus Jansen	Chief Medical Officer